| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.31 | 1e-09 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.24 | 2e-09 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.29 | 5e-09 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.41 | 4e-08 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.24 | 7e-08 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.24 | 7e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.21 | 7e-07 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.35 | 9e-07 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-06 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.22 | 1e-06 |